To summarize the evidence on the current management and outcomes for metastatic and
recurrent malignant phyllodes tumors (MPTs) of the breast. A systematic literature review of …

Simple Summary Epidermal growth factor receptor variant III (EGFRvIII) is caused by the
deletion of six exons and the fusion of exons 1 to exon 8. EGFRvIII occurs frequently in …

Background As a rapid‐progressing tumor, breast malignant phyllodes tumors (PTs) are
challenged by the lack of effective therapeutic strategies and suitable prognostic markers …

Phyllodes tumours or cystosarcoma phyllodes are fibroepithelial tumours of the breast and
represent 1% of breast tumours. A 20-year-old nullipara presented with an enlarging left …

There are markers of metabolic coupling in breast cancer. Loss of caveolin‑1 (Cav‑1) and
upregulation of monocarboxylate transporters (MCTs), especially MCT1 and MCT4, serve an …

Primary osteosarcoma of the breast (POB) is an aggressive and exceedingly rare tumor, and
cases with onset during lactation are extremely rare. The exact mechanism of POB …

Background The indulgence of artificial intelligence (AI) has been considered recently in the
work up for the detection and diagnosis of breast cancer through algorithms that could …

Abstract Purpose of Review Phyllodes tumor (PT) of the breast is a rare type of fibroepithelial
lesion classically presenting in 40–50-year olds. PTs can present a diagnostic challenge …

Metastatic, malignant phyllodes tumor (PT) of the breast is a rare and aggressive neoplasm.
Currently, there is no agreed upon consensus as to best management practices. A …

Background Phyllodes tumors (PTs) are breast neoplasms with varying degrees of
malignancy, posing challenges in diagnosis and management. This case report focuses on …